A Tolerability Study of ALKS 8700 in Subjects With Relapsing Remitting Multiple Sclerosis (RRMS) EVOLVE-MS-2

Clinical trial NCT03093324 · COMPLETED

Trial details

NCT number: NCT03093324
Sponsor: Biogen
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Relapsing Remitting Multiple Sclerosis

Start date: 2017-03-15
Primary completion: 2019-06-27
Enrollment: 506

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.